MYOS RENS Technology Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| NESN | Nestlé | Outperform |
11
|
CHF96.62 | Buy/Sell | CHF115.58 | 13.85% | 13 | CHF253.27B |
| KO | Coca Cola | Outperform |
18
|
$63.03 | Buy/Sell | $65.84 | 7.89% | 4 | $271.53B |
| PEP | PepsiCo | Outperform |
18
|
$182.19 | Buy/Sell | $187.26 | 1.54% | 7 | $250.47B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | Buy/Sell | $118.92 | 21.53% | 7 | $181.08B |
| GSK | GSK | Outperform |
12
|
£17.75 | Buy/Sell | £17.30 | 12.39% | 12 | £72.39B |
| GL9 | Glanbia | Outperform |
18
|
18.11€ | Buy/Sell | 16.42€ | 14.85% | 7 | 4.75€B |